Targeted Selection of HIV-Specific Antibody Mutations by Engineering B Cell Maturation
View/ Open
science.aay7199.pdf (2.803Mb)
Access Status
Full text of the requested work is not available in DASH at this time ("restricted access"). For more information on restricted deposits, see our FAQ.Author
Saunders, Kevin O.
Wiehe, Kevin
Acharya, Priyamvada
Bradley, Todd
Alam, S. Munir
Go, Eden P.
Scearce, Richard
Sutherland, Laura
Henderson, Rory
Hsu, Allen
Borgnia, Mario
Chen, Haiyan
Lu, Xiaozhi
Wu, Nelson R.
Jiang, Chuancang
Easterhoff, David
Cheng, Hwei-Ling
Chapdelaine-Williams, Aimee M.
Eaton, Amanda
Zhang, Jinsong
Rountree, Wes
Verkoczy, Laurent
Tomai, Mark
Lewis, Mark G.
Reed, Steven G.
Desaire, Heather R.
Edwards, Robert J.
Cain, Derek W.
Bonsignori, Mattia
Montefiori, David
Haynes, Barton F.
Haynes, Barton
Published Version
https://doi.org/10.1126/science.aay7199.Metadata
Show full item recordCitation
Saunders, Kevin O, Kevin Wiehe, Ming Tian, Priyamvada Acharya, Todd Bradley, S Munir Alam, Eden P Go, et al. 2019. “Targeted Selection of HIV-Specific Antibody Mutations by Engineering B Cell Maturation.” Science (American Association for the Advancement of Science) 366 (6470): 1215.Abstract
Engineering the immune system by design of immunogens to direct antibody maturation is a major goal of vaccinologists. One of the roadblocks preventing HIV vaccine development is the requirement for broadly neutralizing antibodies (bnAbs) to acquire somatic mutations rarely made by activation-induced cytidine deaminase. Here, we designed immunogens that bind with higher affinity to antibodies with improbable mutations than to unmutated precursor antibodies. We demonstrated for two bnAb B cell lineages using knockin mouse models that such immunogens engaged unmutated bnAb precursors, selected for functional improbable mutations, and induced neutralizing antibodies. Structural studies revealed how bnAb precursors interacted with Env and revealed the functions of the elicited improbable mutations. In primates, the CD4 binding site-targeting immunogen induced potent CD4 binding site neutralizing antibodies in macaques. This immunogen design strategy will allow for the delineation of sequential immunogens to direct bnAb development for HIV-1 and other pathogens.Citable link to this page
https://nrs.harvard.edu/URN-3:HUL.INSTREPOS:37374325
Collections
- HMS Scholarly Articles [17875]
Contact administrator regarding this item (to report mistakes or request changes)